UniSa - IRIS Institutional Research Information System

PAPACCIO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.866
NA - Nord America 648
EU - Europa 339
SA - Sud America 89
AF - Africa 5
OC - Oceania 5
Totale 2.952
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 1.588
US - Stati Uniti d'America 632
SG - Singapore 169
RU - Federazione Russa 127
BR - Brasile 83
IT - Italia 83
CN - Cina 37
DE - Germania 27
IE - Irlanda 27
KR - Corea 25
NL - Olanda 20
GB - Regno Unito 15
IN - India 11
VN - Vietnam 9
CA - Canada 8
UA - Ucraina 8
AT - Austria 7
MX - Messico 7
BD - Bangladesh 5
ES - Italia 5
TR - Turchia 5
BE - Belgio 4
FI - Finlandia 4
JP - Giappone 4
AU - Australia 3
FR - Francia 3
PL - Polonia 3
UZ - Uzbekistan 3
AR - Argentina 2
EC - Ecuador 2
HU - Ungheria 2
IQ - Iraq 2
JO - Giordania 2
LK - Sri Lanka 2
RO - Romania 2
ZA - Sudafrica 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
KE - Kenya 1
KI - Kiribati 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SE - Svezia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.952
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.588
Chandler 128
Princeton 95
Singapore 76
Ashburn 53
Moscow 53
Dublin 27
Andover 24
Redwood City 23
Dallas 22
Wilmington 18
Ann Arbor 15
Amsterdam 13
Naples 13
Council Bluffs 11
Nuremberg 10
New York 9
San Francisco 9
Beijing 8
Los Angeles 8
Seattle 8
The Dalles 8
Sarno 6
Washington 6
Munich 5
Vienna 5
Milan 4
Rome 4
Springfield 4
Tokyo 4
Aprilia 3
Boston 3
Brooklyn 3
Chennai 3
Columbus 3
Dhaka 3
Duncan 3
Edinburgh 3
Hangzhou 3
Ho Chi Minh City 3
Houston 3
New Delhi 3
Norwalk 3
Paris 3
Phoenix 3
Tashkent 3
Toronto 3
Warsaw 3
Amman 2
Assago 2
Atlanta 2
Barbacena 2
Bourne End 2
Budapest 2
Campinas 2
Campo Grande 2
Castellammare di Stabia 2
Chicago 2
Cuiabá 2
Curitiba 2
Ferrara 2
Guarulhos 2
Islington 2
Istanbul 2
Jacksonville 2
Johannesburg 2
Lappeenranta 2
Madrid 2
Manassas 2
Mexico City 2
Montreal 2
Poggiomarino 2
Poplar 2
Porto Alegre 2
Pune 2
San Jose 2
São Paulo 2
The Bronx 2
Weifang 2
Yubileyny 2
Addis Ababa 1
Alto Jequitibá 1
Amparo do Serra 1
América 1
Ankara 1
Anápolis 1
Apizaco 1
Aracaju 1
Areia Branca 1
Artur Nogueira 1
Atibaia 1
Aydin 1
Bacabal 1
Bady Bassitt 1
Baghdad 1
Baldwin 1
Balıkesir 1
Baoding 1
Barishal 1
Belo Horizonte 1
Totale 2.395
Salva come PNG Salva come JPEG
Nome #
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 823
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 332
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 185
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 161
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 140
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 66
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 59
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 54
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 48
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 46
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 46
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 45
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 43
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 42
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 41
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 41
Implication of the Hedgehog pathway in hepatocellular carcinoma 40
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 38
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 37
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 36
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 36
In the literature: August 2018 35
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 35
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 34
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 32
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 31
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 30
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 26
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 26
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids 24
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 24
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 22
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 22
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 22
Circulating cancer stem cells: an interesting niche to explore 19
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 19
Stemness markers of osteosarcoma 19
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 18
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 18
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 17
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 17
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 16
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 16
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 15
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 14
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 14
Will Organoids Fill the Gap towards Functional Precision Medicine? 14
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 13
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 13
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 13
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 12
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 12
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 10
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 10
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 10
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 9
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 9
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 9
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 9
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 9
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 8
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 8
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 7
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 6
Patient-derived organoids as a tool for modelling localized colorectal cancer 4
Totale 3.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 25 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/2025630 8 24 37 17 27 76 107 34 95 40 72 93
2025/20261.687 841 846 0 0 0 0 0 0 0 0 0 0
Totale 3.109